Life Technologies traded at $2.85 this Friday July 1st, increasing $0.02 or 0.71 percent since the previous trading session. Looking back, over the last four weeks, Life Technologies gained 1.38 percent. Over the last 12 months, its price fell by 41.12 percent. Looking ahead, we forecast Life Technologies to be priced at 2.77 by the end of this quarter and at 2.55 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
2.85
Daily Change
0.71%
Yearly
-41.12%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Applied Genetic Technologies 0.78 0.01 1.31% -81.07%
Ardelyx 0.59 0.004 0.70% -92.47%
Biogen 210.63 6.69 3.28% -39.60%
Bristol-Myers Squibb 76.84 -0.16 -0.21% 14.77%
Chimerix 2.14 0.06 2.88% -74.31%
Curis 0.94 -0.04 -4.50% -87.74%
Galapagos 53.06 -1.04 -1.92% -8.30%
GlaxoSmithKline 1,802.60 17.00 0.95% 25.84%
Life Technologies 2.85 0.02 0.71% -41.12%
Novartis 81.65 1.32 1.64% -3.02%
NanoString Technologies 13.15 0.45 3.54% -79.00%
Roche Holding 322.10 1.70 0.53% -8.06%
United Therapeutics 238.00 2.36 1.00% 29.12%
Xoma 20.84 -1.44 -6.46% -37.42%


Life Technologies
aTyr Pharma Inc is a United States-based biotechnology company. The Company engaged in the development of medicines based on biology. The Company’s research and development efforts are concentrated on a new discovered area of biology, the extracellular functionality and signaling pathways of tRNA synthetases.